INDV vs OPCH: fair value comparison
Indivior Pharmaceuticals, Inc. and Option Care Health, Inc. · Updated 2026-10-19
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, OPCH currently sits closer to the top of our ranking by discount to fair value.
| INDV | OPCH | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $32.45 | $31.20 |
| 12-month range | $24.78–$41.83 | $19.52–$36.59 |
| Rank by discount to fair value | #17 of 108 Healthcare | #15 of 108 Healthcare |
| Quality grade | F | F |
| Leverage | Low | Moderate |
| Margin trend | Stable | Stable |
| Revenue growth | Modest | Strong |
| RSI zone | Neutral | Overbought |
| 50/200-day trend | Mixed | Mixed |
| DCF cross-check | — | Fairly Valued |
| 52-week position | The lower-middle quarter | The upper-middle quarter |
Full single-stock breakdowns: INDV fair value analysis · OPCH fair value analysis